ArticleAsia-Pacific journal of oncology nursing2025
Using journey mapping to understand the experience and need for patients with chimeric antigen receptor T-cell therapy.
Article in Asia-Pacific journal of oncology nursing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Humanistic Care Needs of Elderly Chronic Disease Inpatients from the Perspective of Patient Journey Mapping: A Qualitative Study.Patient preference and adherence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To map the journey and needs of patients receiving chimeric antigen receptor T-cell (CAR-T) therapy, providing a reference for improving the comprehensive management of patients receiving clinical CAR-T cell therapy, as well as enhancing patients' overall well-being. Methods: A qualitative grounded theory approach was used. From August 2024 to January 2025, patients receiving CAR-T cell therapy at a university hospital in Wuhan, China, were enrolled through purposive sampling. The research data were collected from descriptive observation, focused observation, and selective observation. The data were analysed with open, axial and selective coding. Patient journey mappings were employed to visualize information regarding patients' experiences and needs. Results: Three main categories, seven subcategories and one core category were used to map the journey of patients receiving CAR-T cell therapy. The core category was curing the disease, and the main categories were complex physical journeys characterized by the struggle against discomfort as a side effect of treatment, individualized psychological journeys created by the hope of a cure and anxiety over side effects, the unpredictable physiological challenges and emotional upheavals inherent to progressively build multidimensional care needs. Patient journey mapping of patients receiving CAR-T cell therapy was designed. Conclusions: The experiences and multidimensional care needs of patients receiving CAR-T cell therapy vary at different stages of treatment. Therefore, it is essential that health care professionals provide attention and support at these times. Patient journey mapping may contribute as a review and audit tool, or a mechanism for providing proactive patient-centred care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.